RxDoctor Payments DataLook up a doctor →

Rajeev Shenoy, MD

Nephrology · Columbia, SCNPI 1467485102

Payments from drug & device makers

$8,077in general payments, 2019–2025

Across 351 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • AstraZeneca$749
  • Amgen$747
  • Novartis$716
  • Otsuka America Pharmaceutical, Inc.$605
  • Vifor Pharma, Inc.$568
  • plus $4K from 38 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic11$1,120
AstraZeneca(2 entities)44$749
Amgen(2 entities)40$747
Novartis42$716
Otsuka America Pharmaceutical, Inc.27$605
Vifor Pharma, Inc.23$568
Calliditas Therapeutics US Inc.20$412
Aurinia Pharma U.S., Inc.13$409
Travere Therapeutics, Inc.12$270
Fresenius USA Marketing, Inc.16$267
Bard Peripheral Vascular, Inc.11$225
Bayer11$209
GSK13$208
Mallinckrodt Hospital Products Inc.5$204
OPKO Pharmaceuticals, LLC10$163
Cordis US CORP.1$125
Daiichi Sankyo Inc.5$108
Akebia Therapeutics Inc6$88
Nxstage Medical, Inc.1$80
Ardelyx, Inc.3$74
Novo Nordisk3$73
VBI Vaccine (delaware) Inc.3$67
Sanofi3$57
Apellis Pharmaceuticals, Inc.2$55
Otsuka Pharmaceutical Development & Commercialization, Inc.2$49
Scpharmaceuticals Inc.2$45
Boehringer Ingelheim2$41
ANI Pharmaceuticals, Inc.2$40
Lilly USA, LLC2$33
Cvrx, Inc.2$32
Lemaitre Vascular, Inc.1$22
Genentech USA, Inc.1$22
Alnylam Pharmaceuticals Inc.1$21
Shield Therapeutics Inc1$19
Johnson & Johnson1$19
Molnlycke Health Care US, LLC1$18
Cormedix Inc.1$17
Xeris Pharmaceuticals, Inc.1$17
Recordati_rare_diseases_inc.1$16
Ascendis Pharma Endocrinology Inc1$16
Lundbeck LLC1$16
BD1$15
Mallinckrodt Enterprises LLC1$13
Biomerieux Inc1$9

How this compares

$8,077 in reported general payments places this provider in the 75th percentile of 180 nephrology providers in South Carolina.

See all nephrology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$177,332
Medicare patients
619
Services billed
3,665

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Columbia

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →